TABLE 1.
Characteristics | ER group (n = 20) | CR group (n = 20) | HC group (n = 20) | p |
Age (year) | 65.25 ± 4.15 | 64.95 ± 3.99 | 66.15 ± 3.58 | 0.52 |
Sex, male/female | 9/11 | 10/10 | 11/9 | 0.819 |
Hoehn and Yahr | 1.37 ± 0.41 | 1.32 ± 0.36 | – | 0.395 |
Disease duration (year) | 2.23 ± 1.69 | 2.28 ± 1.53 | – | 0.095 |
Symptom-dominant side (R/L) | 12/8 | 12/8 | – | 1 |
Daily levodopa dosage (mg/day) | 227 ± 116 | 230 ± 113 | – | 0.102 |
Length of lower limbs (cm) | 83.76 ± 4.45 | 84.75 ± 4.82 | 83.99 ± 4.75 | 0.232 |
ER, enriched rehabilitation; CR, conventional rehabilitation; HC, healthy control.